Key result
ZSF1-obese HFpEF model exhibits marked transcriptional remodeling and impaired mitochondrial energy metabolism.
Why the study?
Heart failure with preserved ejection fraction accounts for approximately 50% of HF cases, motivating a systems-biology approach to define metabolic and transcriptional signatures and gain mechanistic insight into pathways contributing to HFpEF development.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating in HFpEF rat model; leaves open clinical translation pending validation studies.
Heart failure with preserved ejection fraction (HFpEF) accounts for ∼50% of HF cases. The ZSF1-obese rat model recapitulates clinical features of HFpEF including hypertension, obesity, metabolic syndrome, exercise intolerance, and diastolic dysfunction. We utilized a systems-biology approach to define the metabolic and transcriptional signatures to gain mechanistic insight into pathways contributing to HFpEF development. Male ZSF1-obese, ZSF1-lean hypertensive controls, and WKY (wild-type) controls were compared at 14 weeks of age for extensive physiological phenotyping and left ventricle (LV) tissue harvesting for unbiased-metabolomics, RNA-sequencing, and mitochondrial morphology and function. Utilizing ZSF1-lean and WKY controls enabled a distinction between hypertension-driven molecular changes driving HFpEF pathology, versus hypertension + metabolic syndrome. Comparison of ZSF1-lean vs WKY (ie, hypertension-exclusive effects) revealed metabolic remodeling suggesting increased aerobic glycolysis, decreased β-oxidation, and dysregulated purine and pyrimidine metabolism with few transcriptional changes. ZSF1-obese rats displayed worsened metabolic remodeling and robust transcriptional remodeling highlighted by upregulation of inflammatory genes and downregulation of the mitochondrial structure/function and metabolic processes. Integrated network analysis of metabolomic and RNAseq datasets revealed downregulation of most catabolic energy producing pathways, manifesting in a marked decrease in the energetic state (ie, reduced ATP/ADP, PCr/ATP). Cardiomyocyte ultrastructure analysis revealed decreased mitochondrial area, size, and cristae density, as well as increased lipid droplet content in HFpEF hearts. Impaired mitochondrial function was demonstrated by decreased substrate-mediated respiration and dysregulated calcium handling. Collectively, the integrated omics approach applied here provides a framework to uncover novel genes, metabolites, and pathways underlying HFpEF, with an emphasis on mitochondrial energy metabolism as a potential interventional target.
No takes yet. Share an insight, caveat, or question.
Gibb et al. (2025) studied Heart failure with preserved ejection fraction (HFpEF). ZSF1-obese rat model (hypertension + metabolic syndrome) vs. ZSF1-lean hypertensive controls and WKY (wild-type) controls was evaluated on Metabolic and transcriptional signatures. The ZSF1-obese rat model of HFpEF exhibited robust transcriptional and metabolic remodeling, with marked downregulation of mitochondrial energy metabolism and decreased energetic state.
Synapse has enriched 10 related papers. Consider them for comparative context: